Back to search

University of British Columbia

Development of aptamer-based graphene field-effect transistors for determination of protein biomarkers

Abstract

dc:description

Aptamer-based graphene field-effect transistor (GFET) biosensors, known as GFET aptasensors, has gained considerable attention because of their rapidity and accuracy in terms of quantification of a wide range of biomarkers. Development of GFET aptasensors is considered as a cutting-edge technology which can be used early-stage for preventative care and personalized medicine. Biochemical functionalization of graphene channel of GFETs using aptamers, as the biorecognition elements (BREs), is a crucial step in fabrication of GFET aptasensors. This work presents a comprehensive comparison of well-established biochemical functionalization approaches applied for the fabrication of sensing films in GFET aptasensors, namely indirect and direct immobilization of BREs. This study is the first of its kind to experimentally compare the two BREs immobilization approaches in terms of their effects on the carrier mobility of the monolayer graphene channel and their suitability for sensing applications. Experimental results confirmed that both approaches can preserve and even improve the carrier mobility of bare graphene channel and hence the sensitivity of the GFET, however, the direct BREs immobilization method was selected to develop an aptameric GFET biosensor as this method enables simpler and more efficient fabrication of the graphene-based aptameric sensing layer. The direct BREs immobilization approach was applied to develop GFET aptasensors for determination of two important protein biomarkers 1) tumor necrosis factor-α (TNF-α) and 2) SARS-CoV-2 spike protein (S protein). The TNF-α GFET aptasensor was able to measure TNF-α in a detection range from 10 pg/ml to 10 ng/ml, representative of its physiological level in human sweat. Moreover, the fabricated S protein GFET aotasensor possessed capability to specifically detect various concentrations of S protein with limit of detection (LOD) down to 500 ag/mL, ranging from 500 ag/mL to 5 ng/mL. Taken together, the proposed sensing platform can be steppingstone for realizing diagnostic tools with applications in point-of-care and point-of-use settings.

Degree

thesis:*
Name thesis:degree_name
Master of Applied Science - MASc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Mechanical Engineering
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Khorrami Jahromi, Arash
Contributors dc:contributor
  • Hoorfar, Mina
  • Najjaran, Homayoun

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/79522

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Khorrami Jahromi, Arash. Development of aptamer-based graphene field-effect transistors for determination of protein biomarkers. master's thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/79522